Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Dec;21(12):e3.
doi: 10.1634/theoncologist.2016-0170. Epub 2016 Nov 18.

A Case of Nivolumab-Induced Myositis

Eric Fox  1 , Michael Dabrow  2 , Greg Ochsner  2
Affiliations
Comment

A Case of Nivolumab-Induced Myositis

Eric Fox et al. Oncologist. 2016 Dec.

Abstract

Nivolumab (Opdivo) is a monoclonal antibody classified as an immune modulator. A case is presented of nivolumab-induced myositis, an unlisted side effect.

PubMed Disclaimer

Comment on

References

    1. Kazandjian D, Suzman DL, Blumenthal G, et al. FDA approval summary: Nivolumab for the treatment of metastatic non-small cell lung cancer with progression on or after platinum-based chemotherapy. The Oncologist. 2016;21:634–642. - PMC - PubMed
    1. Deeks ED. Nivolumab: A review of its use in patients with malignant melanoma. Drugs. 2014;74:1233–1239. - PubMed
    1. Yoshioka M, Kambe N, Yamamoto Y, et al. Case of respiratory discomfort due to myositis after administration of nivolumab. J Dermatol. 2015;42:1008–1009. - PubMed
    1. Sakamoto K, Kimura J. Mechanism of statin-induced rhabdomyolysis. J Pharmacol Sci. 2013;123:289–294. - PubMed
    1. Min L, Hodi FS. Anti-PD1 following ipilimumab for mucosal melanoma: Durable tumor response associated with severe hypothyroidism and rhabdomyolysis. Cancer Immunol Res. 2014;2:15–18. - PMC - PubMed